Variant report
Variant | nsv1002841 |
---|---|
Chromosome Location | chr2:49747904-49863227 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:49778479..49781327-chr2:49781867..49783960,2 | K562 | blood: | |
2 | chr2:49843960..49844616-chr2:50371140..50372027,2 | MCF-7 | breast: | |
3 | chr2:49843797..49844715-chr2:50070161..50071037,2 | MCF-7 | breast: | |
4 | chr2:49778479..49781327-chr2:49781867..49783960,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs116096613 | chr2:49789242-49789243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs9653527 | chr2:49789280-49789281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532712345 | chr2:49789309-49789310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2350323 | chr2:49789338-49789339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565703449 | chr2:49789354-49789355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs148148905 | chr2:49789378-49789379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs141085471 | chr2:49789379-49789380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs150282585 | chr2:49789434-49789435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2882379 | chr2:49789443-49789444 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs188811242 | chr2:49789478-49789479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs558836927 | chr2:49789537-49789538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs570738990 | chr2:49789544-49789545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs4338999 | chr2:49789549-49789550 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs2882380 | chr2:49789554-49789555 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs137892969 | chr2:49789557-49789558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542656700 | chr2:49789563-49789564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534375596 | chr2:49789573-49789574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554600931 | chr2:49789579-49789580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs371337315 | chr2:49789584-49789585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543604015 | chr2:49789625-49789626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs557580792 | chr2:49789638-49789639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191286775 | chr2:49789688-49789689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs4270384 | chr2:49789693-49789694 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs183865056 | chr2:49789698-49789699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572084194 | chr2:49789772-49789773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs559816467 | chr2:49789774-49789775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529651520 | chr2:49789788-49789789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs1498808 | chr2:49789838-49789839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs202207580 | chr2:49789852-49789853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs187073530 | chr2:49789865-49789866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs191886647 | chr2:49789887-49789888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200319032 | chr2:49789922-49789923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs552386895 | chr2:49789924-49789925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs560798259 | chr2:49789959-49789960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs185124022 | chr2:49789960-49789961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs143374317 | chr2:49789962-49789963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs17038957 | chr2:49789969-49789970 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs556293126 | chr2:49789979-49789980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs568271160 | chr2:49789992-49789993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552271050 | chr2:49790204-49790205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs564026153 | chr2:49790222-49790223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs528252652 | chr2:49790263-49790264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs531416347 | chr2:49790274-49790275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546521930 | chr2:49790278-49790279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563506301 | chr2:49790279-49790280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs532226961 | chr2:49790303-49790304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs180765219 | chr2:49790311-49790312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs535414034 | chr2:49790314-49790315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs144537307 | chr2:49790385-49790386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs569681335 | chr2:49790411-49790412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:49789200-49790000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr2:49789800-49790000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr2:49790200-49791400 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
4 | chr2:49791400-49791800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
5 | chr2:49793600-49794200 | Enhancers | Fetal Brain Male | brain |
6 | chr2:49794200-49796600 | Weak transcription | Fetal Brain Male | brain |
7 | chr2:49796600-49797000 | Enhancers | Fetal Brain Male | brain |
8 | chr2:49810000-49811600 | Enhancers | Fetal Stomach | stomach |
9 | chr2:49825200-49826200 | Enhancers | Fetal Heart | heart |
10 | chr2:49847800-49848800 | Enhancers | Fetal Heart | heart |
11 | chr2:49848400-49849000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr2:49859000-49866400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |